Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.

Lee NJ, Oh JH, Ban JO, Shim JH, Lee HP, Jung JK, Ahn BW, Yoon DY, Han SB, Ham YW, Hong JT.

Br J Pharmacol. 2013 Mar;168(5):1133-45. doi: 10.1111/j.1476-5381.2012.02235.x.

2.

4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity.

Oh JH, Ban JO, Cho MC, Jo M, Jung JK, Ahn B, Yoon DY, Han SB, Hong JT.

J Nutr Biochem. 2012 Jul;23(7):706-15. doi: 10.1016/j.jnutbio.2011.03.013. Epub 2011 Aug 4.

PMID:
21820300
4.

Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.

Ban JO, Oh JH, Son SM, Won D, Song HS, Han SB, Moon DC, Kang KW, Song MJ, Hong JT.

Cancer Biol Ther. 2011 Aug 15;12(4):288-96. Epub 2011 Aug 15.

PMID:
21613824
5.

Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells.

Laurenzana A, Balliu M, Cellai C, Romanelli MN, Paoletti F.

PLoS One. 2013;8(3):e58267. doi: 10.1371/journal.pone.0058267. Epub 2013 Mar 4.

6.

Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.

Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, Ng HK, Ho SM, Lau KM.

Cell Death Differ. 2010 Sep;17(9):1511-23. doi: 10.1038/cdd.2010.20. Epub 2010 Mar 5.

7.

Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB.

Lee SY, Yuk DY, Song HS, Yoon do Y, Jung JK, Moon DC, Lee BS, Hong JT.

Eur J Pharmacol. 2008 Mar 17;582(1-3):17-25. doi: 10.1016/j.ejphar.2007.12.027. Epub 2008 Jan 5.

PMID:
18241858
8.

Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.

Wang Z, Lee HJ, Chai Y, Hu H, Wang L, Zhang Y, Jiang C, Lü J.

Curr Cancer Drug Targets. 2010 May;10(3):307-18.

PMID:
20370687
9.

Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.

Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.

Oncogene. 2001 May 24;20(23):2927-36.

10.

Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.

Chilampalli C, Guillermo R, Kaushik RS, Young A, Chandrasekher G, Fahmy H, Dwivedi C.

Exp Biol Med (Maywood). 2011 Nov;236(11):1351-9. doi: 10.1258/ebm.2011.011030. Epub 2011 Sep 9.

PMID:
21908486
11.

Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.

Sankpal UT, Abdelrahim M, Connelly SF, Lee CM, Madero-Visbal R, Colon J, Smith J, Safe S, Maliakal P, Basha R.

Prostate. 2012 Nov;72(15):1648-58. doi: 10.1002/pros.22518. Epub 2012 Apr 2.

PMID:
22473873
12.
13.

Proapoptotic PEDF functional peptides inhibit prostate tumor growth--a mechanistic study.

Gong Q, Qiu S, Li S, Ma Y, Chen M, Yao Y, Che D, Feng J, Cai W, Ma J, Yang X, Gao G, Yang Z.

Biochem Pharmacol. 2014 Dec 1;92(3):425-37. doi: 10.1016/j.bcp.2014.09.012. Epub 2014 Sep 28.

PMID:
25261795
14.
15.

A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling.

Hafeez BB, Siddiqui IA, Asim M, Malik A, Afaq F, Adhami VM, Saleem M, Din M, Mukhtar H.

Cancer Res. 2008 Oct 15;68(20):8564-72. doi: 10.1158/0008-5472.CAN-08-2232.

16.
18.
19.

Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.

Hahm ER, Arlotti JA, Marynowski SW, Singh SV.

Clin Cancer Res. 2008 Feb 15;14(4):1248-57. doi: 10.1158/1078-0432.CCR-07-1926.

20.

Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.

Liu YQ, Hu XY, Lu T, Cheng YN, Young CY, Yuan HQ, Lou HX.

PLoS One. 2012;7(5):e38000. doi: 10.1371/journal.pone.0038000. Epub 2012 May 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk